163sek
1,9 %
Date:2025-05-23Time:18:00:00Latest report:Q4-2024List:SpotlightTicker:BIOWKS
Market Cap:128 msekEnterprise Value:94 msekNet Sales:25,5 msekEarnings:-37,4 msekEmployees:0ISIN:SE0007387089

Ratios

10-year key figure history for Bio-Works turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Bio-Works with index and moving average MA50 and MA200.

Stockprice:1,63
MA50:1,35
MA200:1,15
Price/MA200:41,9 %
RSI (14):73,0
Price/MA50:20,6 %

Description

Bio-Works Technologies is a biotechnology company. The company develops products that separate and purify molecules in the production of drugs. The technology is based on chromatography that aims to handle the drug substance. Customers are found in the European market where products are sold through distribution partners and to companies in the pharmaceutical industry. They are also sold to research institutes and universities. The company was founded in 2006 and is headquartered in Uppsala.

Pharmaceuticals